01. The Challenge
A Supply Chain Under Pressure
A Fortune 500 pharmaceutical company was facing a mounting crisis: lead times had increased 15% in 18 months, critically delaying the distribution of life-saving medications. With 340 active suppliers across 28 countries and zero real-time visibility, the operations team was managing by instinct rather than data.
A single delayed shipment of active pharmaceutical ingredients could halt production lines serving 12 million patients globally.
Previous optimization attempts had relied on legacy ERP data that was months out of date. The client needed an independent, ground-truth assessment of their entire supplier network, distribution bottlenecks, and demand volatility patterns to build a truly resilient supply chain.
02. Our Approach
End-to-End Supply Chain Intelligence
We deployed an 8-week research program combining primary supplier audits, customer demand analysis, and advanced logistics modeling to identify intervention points invisible to standard ERP systems.
Supplier Network Audit
Conducted structured interviews with 180 Tier-1 and Tier-2 suppliers to identify hidden single-source dependencies and geographic concentration risks.
Demand Signal Analysis
Analyzed 36 months of order data across 6 distribution hubs to build demand forecasting models with 94% accuracy.
Bottleneck Modeling
Simulated 200+ supply disruption scenarios to rank bottlenecks by revenue impact, prioritizing the 12 highest-risk nodes.
03. Research Methodology
Research Methods Deployed
Supplier Surveys
Structured questionnaires sent to 340 active suppliers covering capacity, lead time variability, and financial stability.
Stakeholder Interviews
60-minute deep dives with 35 logistics managers, procurement heads, and regional distribution leads.
Industry Benchmarking
Compared supply chain KPIs against 8 peer pharmaceutical companies to identify relative performance gaps.
Predictive Analytics
ML models trained on 5 years of historical shipment data to forecast demand within a 6% margin of error.
04. Key Findings
Hidden Vulnerabilities Exposed
01
63% of Delays Traced to 4 Suppliers
Despite having 340 suppliers, our analysis revealed that 63% of all lead time delays originated from just 4 Tier-2 chemical suppliers in a single geographic region — none of which were visible in the client's ERP system.
"
We thought we had supply chain visibility. Zapulse showed us we were looking at a mirror, not a window. The real risks were two layers deep.
— Chief Supply Chain Officer
02
Demand Forecasting Error Was 3x Industry Average
The client's internal forecasting had an average error rate of 31%, versus an industry benchmark of 11%. This excess variance was causing $6M in annual over-stocking and $12M in emergency air freight costs.
05. The Results
Measurable Transformation
22% Lead Time Reduction
By qualifying 12 alternative suppliers and renegotiating SLAs with the 4 high-risk primary suppliers, average lead times dropped from 34 to 26.5 days within 3 months.
$18M Annual Cost Savings
Reduced emergency air freight by 71% and overstock by 44%, generating $18M in year-one savings that fully covered the research investment within 6 weeks.
Real-Time Risk Dashboard
Delivered a live supplier risk scoring model integrated into the client's existing ERP, providing continuous visibility across all 340 suppliers for the first time.
06. Client Perspective
In Their Own Words
"
Zapulse gave us something our internal teams couldn't: an honest, unfiltered view of our supply chain's vulnerabilities. The ROI was visible within a quarter.
Sandra Okonkwo
Chief Supply Chain Officer
